Next Article in Journal
Sex and Age-Based Differences in Immune Responses to a Peptide Vaccine for Melanoma in Two Clinical Trials
Previous Article in Journal
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age
Previous Article in Special Issue
The Role of Mucosal-Associated Invariant T Cells in Viral Infections and Their Function in Vaccine Development
 
 
Review

Article Versions Notes

Vaccines 2025, 13(2), 193; https://doi.org/10.3390/vaccines13020193
Action Date Notes Link
article xml file uploaded 16 February 2025 08:05 CET Original file -
article xml uploaded. 16 February 2025 08:05 CET Update https://www.mdpi.com/2076-393X/13/2/193/xml
article pdf uploaded. 16 February 2025 08:05 CET Version of Record https://www.mdpi.com/2076-393X/13/2/193/pdf
article html file updated 16 February 2025 08:07 CET Original file https://www.mdpi.com/2076-393X/13/2/193/html
Back to TopTop